William H. Slattery, III, M.D.

  • Treatment and Management of Neurofibromatosis Type II
  • Treatment of Acoustic Neuromas
  • Implantable Hearing Aids
  • Facial Nerve Paralysis

Slattery WH III, Schwartz MS, Fisher lM, Oppenheimer M. Acoustic neuroma surgical cost and outcome by hospital volume in California. Otolaryngology Head Neck Surgery 2004; 130:726-35.

Slattery WH III, Fisher lM, Iqbal Z, Oppenheimer M. Vestibular schwan noma growth rates in neurofibromatosis type" natural history consortium subjects. Otol NeurotoI2004;25(5):811-7.

Slattery WH III, Fisher lM, Iqbal Z, Liu, N. Oral steroid regimens for idiopathic sudden sensorineural hearing loss. Otolaryngology Head Neck Surgery 2005;132(1);5-10.

Slattery WH III, lev MH, Fisher, lM, Connell SS, Iqbal Z, Go Jl. MRI evaluation of neurofibromatosis type II patients: A standardized approach for accuracy in interpretation. Otol Neurol, 2005; 26:733-740.

Slattery WH III, Fisher lM, Iqubal Z, Friedman RA, Liu N. Intratympanic steroid injection for treatment of idiopathic sudden hearing loss. Otolaryngology Head and Neck Surgery, 2005;133:251-259.

Slattery WH, Fisher lM, Hitselberger W, Friedman RA, Brackmann D. Hearing preservation surgery for neurofibromatosis Type 2-related vestibular Schwannoma in pediatric patients. J Neurosurg:Peds. 2007; 106:255-260.

Fisher LM, Doherty JK, Lev MH, Slattery WH Distribution of nonvestibular cranial nerve Schwannomas in neurofibromatosis 2. Otol & Neuroto/28:1083-1090, 2007.

Evans DG, Kalamarides M, Hunter-Schaedle K, Blakeley J, Slattery WH, et al. Consensus recommendations to accelerate clinical trials for neurofibromatosis type 2. Clin Cancer Res 2009; 15(16):5032-5039.

Fisher lM, Doherty JK, lev MH, Slattery WH III. Concordance of bilateral vestibular schwannoma growth and hearing changes in neurofibromatosis 2: NF2 Natural History Consortium. Otology & Neurotology, 2009 (in press).

Rauch, SD, Reda 0 , Halpin CF, Antonellit PJ, Babu S, Carey JP, Gantz BJ, Goebel JA, Hammerschlag PE, Harris JP, Isaacson B, Lee D, Linstrom CJ, Parnes, lS, Shi H, Slattery WH, et al. Oral vs Intratympanic Corticosteroid Therapy for Idiopathic Sudden Sensorineural Hearing Loss. (Submitted to NEJM). August 2010.